Training program on new long-acting HIV injectable Cabotegravir for PrEP and Cabotegravir/Rilpivirine for treatment. Dr. Amy Colson addresses efficacy, benefits and challenges of long-acting injectables, where and how to administer, dosing schedules, and comparisons to oral medication.
Speaker: Amy Colson, MD Research Director Community Research Initiative
Continuing education credit is not available for this recording.
A variety of the listed topics will be discussed at this event.